Cleared Traditional

K110803 - SURESIGNS VSI VITAL SIGNS MONITOR

K110803 is the FDA 510(k) clearance for SURESIGNS VSI VITAL SIGNS MONITOR by Philips Medical Systems. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 58-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2011
Decision
58d
Days
Class 2
Risk

K110803 is an FDA 510(k) clearance for the SURESIGNS VSI VITAL SIGNS MONITOR. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Philips Medical Systems (Andover, US). The FDA issued a Cleared decision on May 20, 2011 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Philips Medical Systems devices

Submission Details

510(k) Number K110803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2011
Decision Date May 20, 2011
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 492
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K110803.
SURESIGNS VS2+ -SURESIGNS VSI
K112652 · Philips Medical Systems · Oct 2011
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR
K112320 · Health & Life Co., Ltd. · Sep 2011
MICROLIFE AUTOMATIC TALKING BLOOD PRESSURE MONITOR
K111652 · Microlife Intellectual Property GmbH · Jul 2011
SURESIGNS VS2 VITAL SIGNS MONITOR
K111114 · Philips Medical Systems · May 2011
HEM-4030
K110501 · Omron Healthcare, Inc. · Mar 2011
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K110018 · Andon Health Co, Ltd. · Mar 2011